Yasmin E S de Wit, Ido J Bontekoe, Rick van Andel, Thomas R L Klei, Anja Ten Brinke, Sacha S Zeerleder
{"title":"血液采集技术和处理影响血小板产物的核小体和补体含量。","authors":"Yasmin E S de Wit, Ido J Bontekoe, Rick van Andel, Thomas R L Klei, Anja Ten Brinke, Sacha S Zeerleder","doi":"10.1111/vox.70031","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and objectives: </strong>Platelet concentrates (PCs) available for transfusion are prepared either from whole blood donations or by platelet aphaeresis procedures. These different preparation methods may potentially affect damage-associated molecular patterns (DAMPs) and complement activation products in PC, which are associated with adverse reactions (ARs).</p><p><strong>Materials and methods: </strong>The objective of this study is to perform a comparison of platelet activation, nucleosome, mitochondrial DNA (mtDNA), haem and complement activation between differently produced leukoreduced PC. Single donor aphaeresis-PC stored in either plasma or platelet additive solution (PAS)-E and pooled buffy-coat (BC)-PC stored in PAS-E were produced in a regional setting of the Dutch Blood Establishment. For BC-PC, a pool of five BC-independent donors was used, and BC-PCs were grouped based on the time of donation (morning vs. afternoon). Directly after production, samples were collected from PC, and CD62P+ platelets, nucleosomes, mtDNA, haem and complement activation products were measured. A comparison was made between aphaeresis-PC and BC-PC.</p><p><strong>Results: </strong>Higher levels of CD62P+ platelets were observed after stimulation in aphaeresis-PC than BC-PC. The levels of nucleosomes and C4b/c were significantly increased in BC-PC compared to aphaeresis-PC. In addition, the levels of elastase-α1-antitrypsin complexes (EA) were higher in BC-PC from morning blood collections than in aphaeresis-PC or BC-PC from afternoon blood collections, which indicates increased neutrophil activation.</p><p><strong>Conclusion: </strong>Aphaeresis-PC can be better activated than BC-PC. BC-PC contains higher levels of nucleosomes and EA, most likely due to the presence of neutrophils in the BC. In addition, higher levels of complement activation products were observed in BC-PC.</p>","PeriodicalId":23631,"journal":{"name":"Vox Sanguinis","volume":" ","pages":""},"PeriodicalIF":1.8000,"publicationDate":"2025-04-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Blood collection technique and processing impact the nucleosomes and complement contents of platelet products.\",\"authors\":\"Yasmin E S de Wit, Ido J Bontekoe, Rick van Andel, Thomas R L Klei, Anja Ten Brinke, Sacha S Zeerleder\",\"doi\":\"10.1111/vox.70031\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background and objectives: </strong>Platelet concentrates (PCs) available for transfusion are prepared either from whole blood donations or by platelet aphaeresis procedures. These different preparation methods may potentially affect damage-associated molecular patterns (DAMPs) and complement activation products in PC, which are associated with adverse reactions (ARs).</p><p><strong>Materials and methods: </strong>The objective of this study is to perform a comparison of platelet activation, nucleosome, mitochondrial DNA (mtDNA), haem and complement activation between differently produced leukoreduced PC. Single donor aphaeresis-PC stored in either plasma or platelet additive solution (PAS)-E and pooled buffy-coat (BC)-PC stored in PAS-E were produced in a regional setting of the Dutch Blood Establishment. For BC-PC, a pool of five BC-independent donors was used, and BC-PCs were grouped based on the time of donation (morning vs. afternoon). Directly after production, samples were collected from PC, and CD62P+ platelets, nucleosomes, mtDNA, haem and complement activation products were measured. A comparison was made between aphaeresis-PC and BC-PC.</p><p><strong>Results: </strong>Higher levels of CD62P+ platelets were observed after stimulation in aphaeresis-PC than BC-PC. The levels of nucleosomes and C4b/c were significantly increased in BC-PC compared to aphaeresis-PC. In addition, the levels of elastase-α1-antitrypsin complexes (EA) were higher in BC-PC from morning blood collections than in aphaeresis-PC or BC-PC from afternoon blood collections, which indicates increased neutrophil activation.</p><p><strong>Conclusion: </strong>Aphaeresis-PC can be better activated than BC-PC. BC-PC contains higher levels of nucleosomes and EA, most likely due to the presence of neutrophils in the BC. In addition, higher levels of complement activation products were observed in BC-PC.</p>\",\"PeriodicalId\":23631,\"journal\":{\"name\":\"Vox Sanguinis\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":1.8000,\"publicationDate\":\"2025-04-22\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Vox Sanguinis\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1111/vox.70031\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"HEMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Vox Sanguinis","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/vox.70031","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"HEMATOLOGY","Score":null,"Total":0}
Blood collection technique and processing impact the nucleosomes and complement contents of platelet products.
Background and objectives: Platelet concentrates (PCs) available for transfusion are prepared either from whole blood donations or by platelet aphaeresis procedures. These different preparation methods may potentially affect damage-associated molecular patterns (DAMPs) and complement activation products in PC, which are associated with adverse reactions (ARs).
Materials and methods: The objective of this study is to perform a comparison of platelet activation, nucleosome, mitochondrial DNA (mtDNA), haem and complement activation between differently produced leukoreduced PC. Single donor aphaeresis-PC stored in either plasma or platelet additive solution (PAS)-E and pooled buffy-coat (BC)-PC stored in PAS-E were produced in a regional setting of the Dutch Blood Establishment. For BC-PC, a pool of five BC-independent donors was used, and BC-PCs were grouped based on the time of donation (morning vs. afternoon). Directly after production, samples were collected from PC, and CD62P+ platelets, nucleosomes, mtDNA, haem and complement activation products were measured. A comparison was made between aphaeresis-PC and BC-PC.
Results: Higher levels of CD62P+ platelets were observed after stimulation in aphaeresis-PC than BC-PC. The levels of nucleosomes and C4b/c were significantly increased in BC-PC compared to aphaeresis-PC. In addition, the levels of elastase-α1-antitrypsin complexes (EA) were higher in BC-PC from morning blood collections than in aphaeresis-PC or BC-PC from afternoon blood collections, which indicates increased neutrophil activation.
Conclusion: Aphaeresis-PC can be better activated than BC-PC. BC-PC contains higher levels of nucleosomes and EA, most likely due to the presence of neutrophils in the BC. In addition, higher levels of complement activation products were observed in BC-PC.
期刊介绍:
Vox Sanguinis reports on important, novel developments in transfusion medicine. Original papers, reviews and international fora are published on all aspects of blood transfusion and tissue transplantation, comprising five main sections:
1) Transfusion - Transmitted Disease and its Prevention:
Identification and epidemiology of infectious agents transmissible by blood;
Bacterial contamination of blood components;
Donor recruitment and selection methods;
Pathogen inactivation.
2) Blood Component Collection and Production:
Blood collection methods and devices (including apheresis);
Plasma fractionation techniques and plasma derivatives;
Preparation of labile blood components;
Inventory management;
Hematopoietic progenitor cell collection and storage;
Collection and storage of tissues;
Quality management and good manufacturing practice;
Automation and information technology.
3) Transfusion Medicine and New Therapies:
Transfusion thresholds and audits;
Haemovigilance;
Clinical trials regarding appropriate haemotherapy;
Non-infectious adverse affects of transfusion;
Therapeutic apheresis;
Support of transplant patients;
Gene therapy and immunotherapy.
4) Immunohaematology and Immunogenetics:
Autoimmunity in haematology;
Alloimmunity of blood;
Pre-transfusion testing;
Immunodiagnostics;
Immunobiology;
Complement in immunohaematology;
Blood typing reagents;
Genetic markers of blood cells and serum proteins: polymorphisms and function;
Genetic markers and disease;
Parentage testing and forensic immunohaematology.
5) Cellular Therapy:
Cell-based therapies;
Stem cell sources;
Stem cell processing and storage;
Stem cell products;
Stem cell plasticity;
Regenerative medicine with cells;
Cellular immunotherapy;
Molecular therapy;
Gene therapy.